NIBEC's__O fundamental__O materials__O research__O has__O generated__O 35__O patents__O and__O has__O been__O translated__O into__O a__O range__O of__O advanced__O commercialised__O products__O through__O technology__O licensing__O and,__O more__O recently,__O via__O a__O number__O of__O Connected__B-ORG Health__I-ORG spin-out__O ventures.__O
These__O spin-outs__O currently__O employ__O over__O 150__O people__O and__O a__O global__O impact__O has__O been__O attained__O with__O world-wide__O sales__O totalling__O more__O than__O &#163;30m__O per__O year,__O with__O significant__O benefits__O to__O patient__O wellbeing__O (numerous__O lives__O saved)__O and__O reduced__O costs__O to__O healthcare__O systems__O for__O patient__O care.__O
This__O success__O has__O led__O to__O the__O establishment__O of__O the__O European__B-ORG Connected__I-ORG Health__I-ORG Alliance,__I-ORG led__O by__O McLaughlin,__B-ORG which__O has__O 150__O members__O including__O Intel__B-ORG and__I-ORG Bosch__I-ORG and__O provides__O a__O strategic__O consultation__O role__O which__O impacts__O directly__O on__O NI__B-ORG Government__I-ORG and__O global__O business__O policy.__O
With__O an__O award__O of__O &#163;5m__B-MISC funding__O we__O have__O established__O the__O Connected__B-ORG Health__I-ORG Innovation__I-ORG Centre__I-ORG (CHIC)__I-ORG as__O an__O industry-centred__O competence__O centre,__O which__O focuses__O on__O rapidly__O translating__O academic__O research__O into__O innovative__O medical__O products.__O
Our__O spin__O out__O companies__O are__O Heartsine__B-ORG Inc.__I-ORG [text__O removed__O for__O publication].__O
[1],__B-ORG Intelesens__I-ORG Ltd__I-ORG [text__O removed__O for__O publication].__O
and__O partially__O owned__O (22%)__O by__O GE__B-ORG Healthcare__I-ORG [2,__O 6,__O 7,__O 8]__O and__O Heartscape__B-ORG Inc.__I-ORG [3]__O which__O was__O sold__O to__O Verathron__O [text__O removed__O for__O publication].__O
All__O company__O products__O are__O well-__O established__O with__O full__O CE__B-ORG and__O FDA__B-ORG approval.__O
The__O product__O portfolio,__O based__O on__O licensed__O NIBEC__B-ORG patents,__O includes__O devices__O such__O as__O PRIME__B-ORG ECG,__I-ORG Vital__I-ORG Signs__I-ORG Wireless__I-ORG Patch,__I-ORG 12-lead__O holter-__O telemonitoring,__O AED__O defibrillators,__O telemonitoring__O platforms,__O ECG__B-ORG electrodes__O and__O a__O range__O of__O algorithms__O to__O licensed__O companies__O such__O as__O Samsung,__B-PER Tyco__I-PER and__O Meridian__B-PER Medical.__I-PER
In__O particular,__O our__O licensed__O electrode__O technology__O has__O created__O the__O world's__O best-selling__O disposable__O ECG__B-ORG electrode__O [3],__B-ORG with__O $70m__O sales__O and__O sold__O by__O Tyco,__B-PER HP,__I-PER Ludlow__I-PER and__O Space__B-ORG Labs,__I-ORG among__O others.__O
The__O Automatic__B-ORG Equipment__I-ORG Defibrillator__I-ORG developed__O with__O Heartsine,__O is__O the__O most__O compact__O AED__O with__O an__O annual__O turnover__O of__O &#163;20m;__B-ORG the__O telemedicine__O based__O 12-lead__O electrodes__O systems__O licensed__O to__O SHL__B-ORG Telemedicine__I-ORG has__O generated__O $5m__O sales__O and__O a__O 120__O electrode__O ECG__O mapping__O system__O called__O PRIME__O ECG__O is__O now__O selling__O via__O Heartscape/Veratron__B-ORG (USA)__I-ORG [3].__I-ORG
Intelesens__O Ltd,__O with__O McLaughlin__B-MISC as__O current__O CTO,__B-ORG has__O developed__O a__O miniaturised__O chest__O worn__O platform__O incorporating__O wireless,__O algorithms__O for__O arrhythmia__O and__O motion__O detection__O and__O impedance-based__O monitoring__O of__O temperature__O and__O respiration__O patterns__O [8].__O
After__O raising__O over__O &#163;6.5m__O of__O investment,__O and__O entering__O strategic__O partnerships__O with__O Mondo__B-PER (2005),__O Intel__B-ORG (2008)__O and__O GE__B-ORG Healthcare,__I-ORG who__O now__O own__O a__O 22%__O stake__O (2011),__O the__O company__O now__O develops__O a__O further__O range__O of__O patented__O products__O including__O chest__O worn__O SpO2__B-ORG monitors,__O supported__O by__O TSB__B-ORG (2012)__O and__O pulse__O wave__O velocity__O sensors.__O
[text__O removed__O for__O publication].__O
Intelesens__O and__O the__O current__O 44__O qualified__O staff__O complement__O is__O set__O to__O rise__O as__O manufacturing__O is__O developed__O worldwide__O via__O GE__B-ORG Healthcare,__I-ORG who__O launched__O in__O the__O US,__B-ORG the__I-ORG Surveillance__I-ORG Carescape__I-ORG 300__O Product__O in__O May__O 2013__O [2].__O
In__O 2011__O Intelesens__O won__O the__O prestigious202f"Most__B-ORG Promising__I-ORG Technology__I-ORG Award"202fat__I-ORG the__O 4th__O Annual__B-ORG Silicon__I-ORG Valley__I-ORG Technology__I-ORG Leaders__I-ORG Awards__I-ORG and__O in__O the__O same__O year__O Intelesens__B-MISC was__O awarded__O class__O 2__O regulatory__O approval__O by__O the__O FDA__B-ORG authorities__O in__O the__O USA__B-LOC [6].__I-LOC
Although__O the__O company__O has__O already__O around__O &#163;1m__B-ORG a__O year__O turnover,__O international__O sales__O of__O its__O defibrillator__O pad__O range__O and__O V-patch__B-MISC sensor__O systems__O is__O increasing__O and__O full__O commercial__O realisation__O is__O expected__O in__O late__O 2013__O when__O GE__O Healthcare__O fully__O launch__O the__O globally__O FDA__B-ORG approved__O `Surveillance__B-ORG Carescape__I-ORG 300',__O which__O brings__O ECG__B-ORG arrhythmia__O recognition,__O respiration__O rate,__O fall__O detection,__O body__O temperature__O and__O heart__O rate__O into__O one__O wearable__O platform__O [2].__O
HeartSine's__O development__O of__O the__O world's__O most__O compact__O AED__B-ORG was__O based__O on__O NIBEC's__B-MISC chest__O impedance__O and__O arrhythmia__O algorithms,__O in__O conjunction__O with__O novel__O bi-phasic__O waveform__O patterns.__O
This__O company__O [text__O removed__O for__O publication],__O employs__O 80__O people__O in__O Belfast__B-LOC and__O Pennsylvania,__B-ORG has__O 2__O NIBEC__B-ORG licensed__O patents__O and__O is__O currently__O exporting__O to__O over__O 40__O countries,__O including__O the__O USA__B-MISC [1].__I-MISC
The__O company__O has__O its__O headquarters__O in__O the__O USA__B-LOC and__O has__O been__O highlighted__O as__O a__O top__O example__O of__O smart__O portable__O lifesaving__O healthcare__O systems.__O
Recently__O one__O of__O Heartsines__B-MISC products__O hit__O the__O headlines__O when__O it__O was__O used__O in__O the__O miraculous__O survival__O of__O former__O Bolton__B-ORG footballer__O Fabrice__B-PER Muamba__I-PER (2012).__O
HeartSine__O now__O manufactures__O 2,500__O units__O a__O month__O and__O as__O noted__O by__O the__O Prime__O Minister__O David__B-PER Cameron__I-PER in__O recent__O speeches,__O its__O AEDs__O are__O to__O be__O found__O in__O the__O White__B-LOC House__I-LOC and__O on__O AirForce__B-ORG One.__I-ORG
They__O are__O also__O favoured__O by__O many__O international__O airlines,__O sports__O bodies__O and__O emergency__O services,__O from__O Shell__B-ORG Oil__I-ORG super-tankers__O to__O American__B-ORG Airlines__I-ORG and__O the__O Singapore__B-LOC EMS__O service__O [1,__O 9].__O
With__O McLaughlin__O as__O a__O Director__O of__O the__O European__B-ORG Connected__I-ORG Health__I-ORG Alliance__I-ORG (&#163;500k__O Collaborative__B-MISC Network__I-MISC &amp;__I-MISC &#163;500k__I-MISC EU),__I-MISC as__O a__O member__O on__O a__O number__O of__O influential__O Government__B-ORG Task__I-ORG Forces__I-ORG (Connected__I-ORG Health__I-ORG and__I-ORG Prosperity__I-ORG Board;__I-ORG the__I-ORG NI__I-ORG Connected__I-ORG Health__I-ORG ECO__I-ORG System__I-ORG Board,__I-ORG the__I-ORG Connected__I-ORG Health__I-ORG Innovation__I-ORG Centre__I-ORG Board)__I-ORG and__O an__O advisor__O to__O Task__B-ORG and__I-ORG Finish__I-ORG Groups__I-ORG on__O the__O subject__O of__O Connected__O Health,__O the__O expertise__O derived__O from__O NIBEC__B-ORG research__O and__O commercial__O realisation__O now__O impacts__O on__O core__O government__O policy__O and__O industry__O direction__O within__O this__O sector__O [4,__O 5].__O
This__O work__O is__O currently__O expanding__O our__O links__O with__O the__O New__B-ORG York__I-ORG State__I-ORG and__O the__O San__B-LOC Diego__I-LOC regions,__O where__O similar__O activities__O are__O growing.__O
The__O ECHAlliance,__B-ORG which__O was__O set__O up__O in__O 2010__O to__O follow-on__O to__O the__O European__B-ORG Connected__I-ORG Health__I-ORG Campus,__I-ORG is__O an__O initiative__O designed__O to__O support__O and__O promote__O the__O wider__O adoption__O of__O healthcare__O and__O wellbeing__O (including__O sports__O and__O fitness)__O products,__O services,__O applications__O and__O innovation.__O
In__O bringing__O together__O commercial,__O academic__O and__O healthcare__O stakeholders,__O ECHAlliance__B-ORG facilitates__O focused__O leadership__O for__O the__O development__O of__O `Connected__B-ORG and__I-ORG MHealth'__I-ORG markets__O and__O practices__O across__O Europe__B-LOC and__O beyond.__O
The__O scope__O includes__O the__O economic__O development__O of__O the__O full__O range__O of__O eHealth,__B-ORG EHR__I-ORG TeleCare,__I-ORG TeleHealth__I-ORG Telemonitoring__I-ORG and__O MHealth__B-LOC sectors.__O
At__O present__O there__O are__O 150__O members__O including__O Intel__B-ORG and__O Bosch.__B-LOC
NIBEC,__B-LOC through__O McLaughlin,__B-LOC in__O partnership__O with__O O'Connor__B-MISC (Chair__I-MISC of__I-MISC the__I-MISC ECHAlliance)__I-MISC have__O played__O a__O pivotal__O role__O in__O establishing__O Connected__B-ORG Health__I-ORG initiatives__O in__O N.__B-LOC Ireland__I-LOC which__O have__O directly__O resulted__O in__O an__O increased__O focus__O at__O ministerial__O level,__O an__O inter-department__O MOU__O between__O our__O Department__B-ORG of__I-ORG Health__I-ORG and__I-ORG our__I-ORG Department__I-ORG of__I-ORG Enterprise__I-ORG and__I-ORG Trade,__I-ORG changes__O in__O policy,__O expanded__O government's__O Connected__B-ORG Health__I-ORG activities__O and__O created__O measurable__O economic__O and__O health__O benefits__O over__O these__O past__O 4__O years__O [4,__O 5].__O
Over__O 50__O local__O companies__O and__O over__O 150__O organisations__O (www.ni-chic.org/ni-capability.html)__O are__O benefiting__O from__O our__O new__O ECO__B-ORG system__O and__O the__O associated__O &#163;10m__O of__O recent__O investments.__O
These__O benefits__O include__O increased__O employment__O (e.g.__O
GE__O Healthcare__O investments__O at__O Intelesens__B-LOC with__O over__O 40__O jobs),__O Foreign__B-ORG Direct__I-ORG Investment__I-ORG (e.g.__I-ORG
Arc__O Devices,__O 10__O jobs__O initially)__O and__O the__O rolling__O out__O of__O new__O systems__O such__O as__O NI's__O Patient__O Record__O System__O involving__O major__O investment__O by__O Orion__B-ORG (15__O R&amp;D__B-ORG jobs).__O
In__O order__O to__O help__O deliver__O the__O impact__O of__O our__O research__O directly__O to__O patient__O wellbeing__O and__O hospital__O economics,__O we__O have__O established__O strong__O links__O with__O regional__O hospital__O trusts__O through__O our__O Centre__O for__O Advanced__B-ORG Cardiology__I-ORG Research,__I-ORG which__O hosts__O cardiologist__O McEneaney__O as__O a__O Visiting__B-ORG Professor.__I-ORG
We__O have__O established__O international__O collaboration__O through__O MoUs__B-ORG and__O formal__O agreements__O with__O e.g.__O
Partners__B-PER Healthcare__I-PER (Massachusetts__O General,__O USA);__O CIMIT__O (Boston)__O and__O many__O other__O international__O hospitals.__O
All__O of__O this__O leads__O to__O device__O adoption__O and__O the__O saving__O of__O lives__O which__O benefits__O this__O region__O significantly.__O
This__O impact__O was__O highlighted__O recently__O at__O the__O Ulster__B-ORG Business__I-ORG Festival__I-ORG and__I-ORG Investment__I-ORG Conference,__I-ORG chaired__O by__O McLaughlin.__B-ORG
Much__O of__O the__O work__O at__O Intelesens__O and__O Heartsine__B-LOC has__O been__O validated__O by__O the__O EPSRC__B-MISC IRC__O MATCH__O Centre__O (Multidisciplinary__O Assessment__O of__O Technology__B-LOC Centre__I-LOC for__O Health)__B-LOC (BM)__I-LOC and__O published__O work__O demonstrates__O up__O to__O 30%__O cost__O savings__O associated__O with__O syncope__O patients__O and__O in__O the__O case__O of__O AED's__O key__O algorithms__O save__O the__O lives__O of__O up__O to__O 20%__O more__O patients__O [10].__O
Similar__O high__O impact__O studies__O have__O been__O highlighted__O in__O the__O MATCH__B-MISC Impact__O Final__O Report__O in__O which__O Dr__B-ORG Mary__I-ORG Jo__I-ORG Kurth__I-ORG of__I-ORG Randox__I-ORG (www.randox.com)__O highlighted__O "The__B-MISC work__O that__O MATCH-NIBEC__B-ORG carried__O out__O has__O been__O critical__O in__O demonstrating__O the__O value__O of__O the__O diagnostic__O test__O and__O has__O been__O widely__O used__O in__O sales__O presentations__O and__O in__O Randox__B-LOC brochures__O thus__O enhancing__O our__O sales."__O
The__O impact__O of__O NIBEC__B-ORG research__O in__O Connected__B-LOC Health__I-LOC related__O disciplines__O can__O be__O summarised__O as__O follows:__O Over__O 150__O jobs__O created__O across__O the__O three__O NIBEC__B-ORG Connected__I-ORG Health__I-ORG spin-out__O companies,__O over__O &#163;37m__O of__O investment__O and__O in__O excess__O of__O &#163;30m__O sales__O per__O year.__O
Low__O cost__O technology__O for__O critical__O care__O use__O which__O saves__O many__O lives__O annually__O (estimated__O to__O be__O hundreds__O per__O year),__O improves__O the__O quality__O of__O life,__O especially__O for__O the__O elderly__O and__O cuts__O costs.__O
Enhanced__O global__O interest__O in__O the__O possibility__O of__O home__O and__O hospital__O based__O wireless__O monitoring__O (e.g.__O
GE__B-ORG Healthcare,__I-ORG Intel__I-ORG investments__O and__O 5__O recent__O inward__O investments)__O Technology__O uptake__O by__O the__O Wellcome__B-ORG Trust,__I-ORG UK__I-ORG Government,__I-ORG CIMIT__I-ORG (Boston)__I-ORG and__O various__O companies__O as__O exemplars__O of__O the__O future__O of__O healthcare__O sensor__O systems.__O
New__O funding__O and__O business__O models__O are__O being__O established__O which__O involve__O strategic__O partnering__O with__O multi-national__O companies__O (e.g.__O
GE__O Healthcare,__O Intel);__O best__O practice__O techniques__O for__O model__O clinical__O agreements;__O platforms__O for__O faster__O FDA__B-ORG and__O CE__B-ORG approval__O and__O encouraging__O the__O high__O quality__O staff__O to__O continuously__O re-train__O and__O develop.__O
Moulded__O the__O shape__O of__O NI__B-ORG Government__I-ORG Strategies,__I-ORG through__I-ORG MATRIX__I-ORG and__O NI__O Innovation__O Strategy__O panels__O and__O inspired__O a__O unique__O MoU__O between__O Department__B-ORG of__I-ORG Health__I-ORG (NI)__I-ORG and__I-ORG Department__I-ORG of__I-ORG Enterprise__I-ORG and__I-ORG Trade__I-ORG in__I-ORG NI.__I-ORG
Our__O research__O has__O highlighted__O the__O value__O of__O tri-lateral__O partnerships__O with__O industry__O (local__O and__O international)__O and__O clinicians__O which__O will__O establish__O market__O and__O clinical__O roadmaps__O for__O each__O product__O family__O along__O with__O field__O testing__O and__O rapid__O feedback.__O
